On Tuesday, ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)’s shares inclined 6.12% to $0.520.
Caladrius Biosciences, Inc. (CLBS), a cell therapy leader with a late-stage clinical program for immuno-oncology, declared recently a new Agreement between its wholly-owned partner, PCT, LLC, a Caladrius Company (“PCT”), and ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT:IMUC), a clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers.
Under this Agreement, PCT will produce ICT-107, a dendritic cell-based immunotherapy targeting six glioblastoma tumor-associated antigens, for a pivotal Phase 3 trial in patients with newly diagnosed glioblastoma. PCT has served as an external manufacturing and development provider for ImmunoCellular since 2011, counting clinical production for ImmunoCellular’s ICT-107 Phase 2 trial.
PCT will provide manufacturing services, counting processing, packaging, labelling, quality control testing, release, shipping and storage, in addition to process requalification, for ICT-107. The agreement comprises the provision of a semi-dedicated controlled environment room and staff to meet ImmunoCellular’s Phase 3 manufacturing needs. Furthermore, ImmunoCellular will make use of PCT’s capability to perform a technology transfer process to harmonize the EU and US methods of production of ICT-107.
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. Its lead product candidate comprises ICT-107, a dendritic cell (DC) vaccine that accomplished Phase II testing trials for the treatment of glioblastoma multiforme (GBM). The company also develops other therapeutic DC vaccines, such as ICT-121 to treat recurrent GBM and other solid tumor cancers; and ICT-140 for ovarian cancer.
Media General Inc (NYSE:MEG)’s shares gained 2.36% to $16.90.
Media General Inc (MEG) one of the nation’s largest connected-screen media companies, recently declared the promotion of John O. Lewis to Vice President and General Manager of WNCT-TV, the CBS and CW associates (WNCT and Eastern North Carolinas CW, respectively) in Greenville, NC.
Mr. Lewis most recently served as the stations’ General Sales Manager for the last four years, assisting to grow ratings and revenue. Prior to that role, he was the Local Sales Manager for WNCT and Eastern North Carolinas CW.
Media General, Inc. owns and operates television stations in the United States. It operates 71 network-associated stations, and their associated digital media and mobile platforms, counting 22 CBS stations, 14 NBC stations, 12 ABC stations, 8 FOX stations, 7 MyNetworkTV stations, 7 CW stations, and 1 Telemundo station in 48 markets. Media General, Inc. was founded in 1850 and is headquartered in Richmond, Virginia.
At the end of Tuesday’s trade, International Game Technology Ordinary Shares (NYSE:IGT)‘s shares dipped -1.19% to $18.27.
International Game Technology Ordinary Shares (IGT) declared that its Annual General Meeting of Shareholders will be held in London, U.K. on July 28, 2015. In accordance with the U.K. Companies Act, IGT’s Board of Directors has established July 24, 2015 as the record date for determining the shareholders entitled to vote at the Meeting.
International Game Technology PLC operates and provides a range of services and technology products across lotteries, machine gaming, sports betting, and interactive gaming markets in North America, Asia, and Europe. It provides online lottery transaction processing systems; a suite of lottery-enabled point-of-sale terminals; supplies instant ticket games; and provides printing services, instant ticket marketing plans, graphic design, and programming, production, packaging, and shipping and delivery services.
TrueCar Inc (NASDAQ:TRUE), ended its Tuesday’s trading session with -1.50% loss, and closed at $12.44.
TrueCar, Inc. (TRUE), the negotiation-free car buying and selling mobile marketplace, declared that it has been granted three new patents by the United States Patent and Trademark Office.
The proprietary data systems patents relate to technology that enables the provision of vehicle pricing information in a manner that supports a transparent consumer experience. That transparency is at the heart of TrueCar’s commitment to connecting TrueCar Certified Dealers to in-market consumers seeking price confidence in the car-buying process.
The USPTO approved TrueCar’s patents Nos. 9,020,844, 9,020,843 and 9,031,967, raising the company’s total to 19. The new patents cover topics counting natural language processing for interpreting text strings – critical in evaluating vehicle listing data – and a method of generating pricing curve distributions based on transactions analysis, which is useful for displaying normalized pricing information to consumers.
TrueCar, Inc. operates as an Internet-based information, technology, and communication services company. The company operates its platform on the TrueCar Website and TrueCar mobile applications. It also customizes and operates its platform for its affinity group marketing partners, counting financial institutions, membership-based organizations, and employee buying programs for large enterprises.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
